Genix Pharmaceuticals Corp
XTSX:GENX

Watchlist Manager
Genix Pharmaceuticals Corp Logo
Genix Pharmaceuticals Corp
XTSX:GENX
Watchlist
Price: 0.02 CAD -33.33% Market Closed
Market Cap: CA$1.2m

Balance Sheet

Balance Sheet Decomposition
Genix Pharmaceuticals Corp

Balance Sheet
Genix Pharmaceuticals Corp

Rotate your device to view
Balance Sheet
Currency: CAD
Oct-2003 Oct-2004 Oct-2005 Oct-2006 Oct-2007 Oct-2008 Oct-2009 Oct-2010 Oct-2011 Oct-2012 Oct-2013 Oct-2014 Oct-2015 Oct-2016 Oct-2017 Oct-2018 Oct-2019 Oct-2020 Oct-2021 Oct-2022 Oct-2023 Oct-2024
Assets
Cash & Cash Equivalents
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
Cash
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
Total Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Assets
0
0
1
0
0
0
0
0
0
1
1
1
0
0
0
0
0
1
0
0
0
0
PP&E Net
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
4
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
1
N/A
1
+3%
1
+10%
0
-87%
0
+111%
0
+58%
0
-3%
0
-52%
0
+36%
1
+342%
1
-25%
1
+24%
1
-21%
0
-27%
0
-13%
0
-41%
0
-83%
5
+13 168%
5
-11%
4
-11%
0
-95%
0
-80%
Liabilities
Accounts Payable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Accrued Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Liabilities
0
N/A
0
+21%
0
-3%
0
-62%
0
+120%
0
-27%
0
+25%
0
-10%
0
+19%
0
-78%
0
-14%
0
+100%
0
-8%
0
-24%
0
+225%
0
-60%
0
-25%
0
+495%
1
+54%
1
+39%
1
+29%
1
-10%
Equity
Common Stock
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
10
10
10
10
10
Retained Earnings
2
2
2
3
3
3
3
3
3
3
3
3
4
4
4
4
4
5
6
7
11
11
Additional Paid In Capital
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
0
N/A
0
-19%
0
+36%
0
N/A
0
-133%
0
N/A
0
N/A
0
-1 200%
0
-8%
1
N/A
1
-25%
1
+16%
1
-23%
0
-27%
0
-67%
0
+1%
0
N/A
5
N/A
4
-17%
3
-20%
1
N/A
1
-4%
Total Liabilities & Equity
1
N/A
1
+3%
1
+10%
0
-87%
0
+111%
0
+58%
0
-3%
0
-52%
0
+36%
1
+342%
1
-25%
1
+24%
1
-21%
0
-27%
0
-13%
0
-41%
0
-83%
5
+13 168%
5
-11%
4
-11%
0
-95%
0
-80%
Shares Outstanding
Common Shares Outstanding
19
19
19
19
19
22
22
22
22
32
32
32
38
38
38
38
38
59
59
59
59
59